Aldeyra Therapeutics Faces Class Action Following FDA's Drug Response Letter Impacting Investors Following a critical letter from the FDA regarding drug efficacy, Aldeyra Therapeutics faces potential class action. Investors with losses encouraged to join.

Aldeyra Therapeutics Faces Class Action Following FDA's Drug Response Letter Impacting Investors #USA #New_York #ALDX #Aldeyra_Therapeutics #Drug_Efficacy